^
    Laboratories can now leverage the oncoReveal Rapid AML Panel as a fast first-pass NGS tool to generate key AML genomic findings while determining the need to run a broader comprehensive genomic profiling (CGP) panel, supporting quicker triage of samples and more efficient downstream testing workflows.
    Cancer:
    Acute Myelogenous Leukemia
    Method:
    Next-Generation Sequencing